AI-generated summary
The authors compared photobiomodulation (red 660 nm laser) with a sham device in head and neck cancer patients receiving radiotherapy, tracking weight and body mass index. They report that the photobiomodulation group lost less weight and had less BMI loss than the sham group, and that oral mucositis severity was reduced, though mucositis was not prevented.
- Who or what was studied
- Patients with head and neck cancer undergoing chemoradiotherapy, divided into a photobiomodulation group (n = 17) and a sham group (n = 19).
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports a small sample split into two groups and does not describe randomization or blinding, and the study was registered retrospectively.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 86.7 mW
- Total energy
- 1 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Sham, Photobiomodulation therapy, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.